Can-Fite BioPharma Ltd. Adjustments For Finance Income Cost
Can-Fite BioPharma Ltd. (CANF) reported Adjustments For Finance Income Cost of -$621.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2020-03-27.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForFinanceIncomeCost · last filed 2020-03-27
| Period end | Adjustments For Finance Income Cost 12 month | Adjustments For Finance Income Cost 12 month as first filed |
|---|---|---|
| 2019-12-31 | -$621.00K 20-F · filed 2020-03-27 | |
| 2018-12-31 | -$1.15M 20-F · filed 2020-03-27 | $1.15M 20-F · filed 2019-03-29 |
| 2017-12-31 | $12.00K 20-F · filed 2020-03-27 | -$12.00K 20-F · filed 2019-03-29 |
| 2016-12-31 | -$319.00K 20-F · filed 2019-03-29 |